The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Bristol Myers Squibb announced that OpdualagTM (nivolumab and relatlimab-rmbw), a new, first-in-class, fixed-dose combination of nivolumab and ...
read more
The FDA has issued the guidance for industry, Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4. This guidance provides ...
read more
Teva Pharmaceuticals has reached an agreement with the Attorney General of Rhode Island that settles the state’s and its subdivisions opioid-related ...
read more
Wednesday, March 23, 2022
Merck announced that Dr. Roy D. Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will ...
read more
Novartis announced that the US Food and Drug Administration (FDA) approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan) (formerly referred to as...
read more
Ligand Pharmaceuticals Incorporated announced the signing of a definitive merger agreement with Avista Public Acquisition Corp. II (APAC), a publicly ...
read more
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...
read more
Merck announced the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending ...
read more
Novavax, Inc. announced that NVX-CoV2373, its protein-based COVID-19 vaccine, is included in two trials now underway to evaluate its vaccine's safety,...
read more
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorization in the ...
read more
Innovent Biologics, Inc. and Eli Lilly and Company announced that in light of both parties' shared commitment to continue bringing innovative ...
read more
The U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 ...
read more
Santhera Pharmaceuticals (and ReveraGen BioPharma, Inc announced the initiation of a rolling new drug application (NDA) submission to the FDA for ...
read more
Australian biotech company Noxopharm announced the FDA granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for use in...
read more
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved a 2 mg dose of Ozempic® (semaglutide) injection, a once-weekly ...
read more